Streamlined synthesis of phosphatidylinositol (PI), PI3P, PI3, 5P 2, and deoxygenated analogues as potential biological probes

Journal of Organic Chemistry

Volumn 71, Issue 13, 2006, Pages 4919-4928

  Xu, Yingju ^a   Sculimbrene, Bianca R ^a   Miller, Scott J ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGENATED ANALOGUES; PHOSPHATIDYLINOSITOL; PHOSPHORYLATION; STREAMLINED SYNTHESIS;

CATALYSIS; MEMBRANES; MOLECULAR DYNAMICS; REACTION KINETICS; SYNTHESIS (CHEMICAL);

ALCOHOLS;

DEOXYGENATED PHOSPHATIDYLINOSITOL DERIVATIVE; FUNCTIONAL GROUP; INOSITOL; NATURAL PRODUCT; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PHOSPHATIDYLINOSITOL 3,5 DIPHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; ASYMMETRIC PHOSPHORYLATION; MEMBRANE; MOLECULAR PROBE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYNTHESIS; TECHNIQUE;

FLUORESCENT DYES; MOLECULAR CONFORMATION; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHATIDYLINOSITOLS; PHOSPHORYLATION; STEREOISOMERISM;

EID: 33745435524     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo060702s     Document Type: Article

References (39)

1. Irvine, R. F.; Schell, M. J. Nature Rev. Mol. Cell. Biol. 2001, 2, 327-338.
2. Prestwich, G. D. Chem. Biol. 2004, 11, 619-637.
3. For examples of syntheses of deoxy-PI-type compounds with saturated side chains, see: (a) Wang, D. S.; Chen, C. S. Bioorg. Med. Chem. 2001, 9, 3165-3172.
4. (b) Hu, Y.; Meuillet, E. J.; Qiao, L.; Berggren, M. M.; Powis, G.; Kozikowski, A. P. Tetrahedron Lett. 2000, 41, 7415-7418.
5. (c) Andresen, T. L.; Skytte, D. M.; Madsen, R. Org. Biomol. Chem. 2004, 2, 2951-2957.
6. For syntheses of PIP-compounds with unsaturated side chains, see: (a) Kubiak, R. J.; Bruziak, K. S. J. Org. Chem. 2003, 68, 960-968.
7. (b) Gaffney, P. R. J.; Reese, C. B. J. Chem. Soc., Perkin Trans. 1 2001, 192-205.
8. (c) Watanabe, Y.; Nakatomi, M. Tetrahedron 1999, 55, 9743-9754.
9. For representative syntheses of PDF-compounds with saturated side chains, see: (a) Morisaki, N.; Morita, K.; Nishikawa, A.; Nakatsu, N.; Fukui, Y.; Hashimoto, Y.; Shirai, R. Tetrahedron 2000, 56, 2603-2614.
10. (b) Falck, J. R.; Krishna, U. M.; Capdevila, J. H. Bioorg. Med. Chem. Lett. 2000, 10, 1711-1713.
11. (c) Painter, G. F.; Grove, S. J. A.; Gilbert, I. H.; Holmes, A. B.; Raithby, P. R.; Hill, M. L.; Hawkins, P. T.; Stephens, L. R. J. Chem. Soc., Perkins Trans. 1 1999, 923-936.
12. (d) Chen, J.; Feng, L.; Prestwich, G. D. J. Org. Chem. 1998, 63, 6511-6522.
13. (e) Wang, D. S.; Chen, C. S. J. Org. Chem. 1996, 61, 5905-5910.
14. (f) Bruzik, K. S.; Kubiak, R. J. Tetrahedron Lett. 1995, 36, 2415-2418.
15. 2-compounds with saturated side chains, see: (a) Falck, J. R.; Krishna, U. M.; Katipally, K. R.; Capderila, J. H.; Ulug, E. T. Tetrahedron Lett. 2000, 41, 4271-4275.
16. (b) Han, F.; Hayashi, M.; Watanabe, Y. Chem. Lett. 2003, 32, 724-725.
17. (c) Han, F.; Hayashi, M.; Watanabe, Y. Eur. J. Org. Chem. 2004, 558-566.
18. (d) Nishikawa, A.; Saito, S.; Hashimoto, Y.; Koga, K.; Shiri, R. Tetrahedron Lett. 2001, 42, 9195-9198.
19. For representative syntheses of PI-compounds, see: Watanabe, Y.; Kiyosawa, Y.; Hyodo, S.; Hayashi, M. Tetrahedron Lett. 2005, 46, 281-284.
20. Xu, Y.; Lee, S. A.; Kutateladze, T. G.; Sprissa, D.; Shisheva, A.; Prestwich, G. D. J. Am. Chem. Soc. 2006, 128, 885-897.
21. (a) Sculimbrene, B. R.; Miller, S. J. J. Am. Chem. Soc. 2001, 123, 10125-10126.
22. (b) Sculimbrene, B. R.; Morgan, A. J.; Miller, S. J. J. Am. Chem. Soc. 2002, 124, 11653-11656.
23. (c) Sculimbrene, B. R.; Morgan, A. J.; Miller, S. J. Chem. Commun. 2003, 1781-1785.
24. Morgan, A. J.; Wang, Y. K.; Roberts, M. F.; Miller, S. J. J. Am. Chem. Soc. 2004, 126, 15370-15371.
25. Sculimbrene, B. R.; Xu, Y.; Miller, S. J. J. Am. Chem. Soc. 2004, 126, 13182-13183.
26. Gani, D. Nature 2001, 414, 703-705.
27. Kubiak, R. J.; Bruzik, K. S. J. Org. Chem. 2003, 68, 960-968.
28. The sequences described below have indeed been executed equivalently in each enantiomeric series for a number of cases. Details of these syntheses, including characterization of enantiomers, are included in the Supporting Information where appropriate. For concise presentation, we describe in the text the preparation of only one enantiomer of each target.
29. Vazquez, F.; Sellers, W. R. Biochim. Biophys. Acta 2000, 1470, M21-M35.
30. Martin, S. F.; Josey, J. A.; Wong, Y. L.; Dean, D. W. J. Org. Chem. 1994, 59, 4805-4820.
31. Reddy, K. K.; Saady, M.; Falck, J. R. J. Org. Chem. 1995, 60, 3385-3390.
32. This reactivity manifold is precedented. See: Atherton, F. R.; Howard, H. T.; Todd, A. R. J. Chem. Soc. 1948, 1106-1111.
33. Dove, S. K.; Piper, R. C.; McEwen, R. K.; Yu, J. W.; King, M. C.; Hughes, D. C.; Thuring, J.; Holmes, A. B.; Cooke, F. T.; Michell, R. H.; Parker, P. J.; Lemmon, M. A. EMBO J. 2004, 23, 1922-1933.
34. (a) Mitsunobu, O. Synthesis 1981, 1-28.
35. (b) Hughes, D. L. Org. React. 1992, 42, 335-656.
36. (c) Hughes, D. L. Org. Prep. Proc. Int. 1996, 28, 127-164.
37. (d) Mitsunobu, O.; Kato, K.; Kimura, J. J. Am. Chem. Soc. 1969, 91, 6510-6511.
38. Mahmoodi, N. O. Phosphorus, Sulfur Silicon 2002, 177, 2887-2893.
39. Hurley, J. H.; Grobler, J. A. Curr. Opin. Struct. Biol. 1997, 7, 557-565.